slides · global inventory
Quote
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,645
Current window 8,221-8,250
Pages 355
Rows per page 30
Component
8,221-8,250 of 10,645
390
The slide highlights a negative expert opinion on a drug being repurposed for PWS.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
392
The slide uses direct quotes and Q&A excerpts to build a case against the safety of the drug Vykat in the context of PWS treatment.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
393
The slide uses highlighted text to emphasize key concerns about Vykat's safety profile and Miller's private skepticism.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
398
The slide uses a Q&A format to expose the contradiction between the drug's intended use and its actual clinical viability.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
401
The slide uses a direct quote to undermine the perceived value of the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
402
The slide highlights a potential competitive threat to Vykat from generic diazoxide.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
403
The slide highlights a contradiction between the drug's intended use and its physiological impact on a vulnerable patient population.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
404
The slide uses a summary paragraph followed by a direct quote, highlighting the expert's negative sentiment.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
405
The slide uses direct quotes from an expert consultation to highlight the drug's perceived lack of efficacy and the barrier of administrative burden.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
408
The slide uses direct quotes from an endocrinologist to frame potential medical risks as a barrier to adoption.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 1 hit
02
The slide uses a bilingual quote (English and Japanese) to set a thematic tone for the presentation.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Monster1 hit
05
The quote highlights a conflict between administrative credit holds and urgent clinical needs for heart transplants.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Testimonials from Industry Experts1 hit
06
The slide uses a direct quote to expose a contradiction between company claims and user experience.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Testimonials from Industry Experts1 hit
07
The slide uses a direct quote to frame TransMedics as a failing company due to poor leadership and predatory behavior, drawing an analogy to Blackberry's decline.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Testimonials from Industry Experts1 hit
19
The slide uses a combination of narrative summary and a direct Q&A transcript excerpt to substantiate claims of unethical conduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.1 hit
21
The slide uses a combination of narrative analysis and direct testimonial quotes to build a bearish case against the company.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
25
The slide uses a 'villain critique' approach to frame the company's business model as a 'government pay scam'.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
29
The slide uses a Q&A format to highlight specific allegations from an industry executive regarding OIG, DOJ, and IRS involvement.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions1 hit
34
The slide uses a 'guilt by association' argument, linking TransMedics to a failed company (Nevro) based on demographic patterns in their user base.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
35
The slide uses a narrative approach to cast doubt on the reputation of a prominent surgeon, linking him to high mortality rates and unethical practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
56
The slide uses a 'he said, she said' structure to highlight a potential fraud or misrepresentation by the CEO.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
57
The slide uses a 'he-said, she-said' structure to frame the company's NOP service as a potential antitrust issue.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
59
The slide uses a Q&A format to highlight the discrepancy between pre-approval and post-approval pricing.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
63
Includes direct quotes from a transplant administrator/executive at MGH.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
66
The slide uses a Q&A format to present expert testimony as evidence of the company's alleged predatory practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
74
The slide uses a Q&A format to build a case for fraudulent billing practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
76
The slide uses a Q&A format to highlight internal confusion and the visibility of national operations via an internal app.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
85
The slide presents a Q&A style interview excerpt to support a claim of extortion/fraud.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
86
The slide highlights a specific geographical proximity (San Ramon) to argue that TransMedics' operational choices are inefficient and costly for transplant centers.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
87
The slide uses a Q&A format to provide primary source evidence for the claims made in the headline.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit